Document:

SECURITIES
PURCHASE AGREEMENT

 

 

THIS
PURCHASE AGREEMENT (“Agreement”) is made as of the 3rd day of November, 2017 by and between Rich Pharmaceuticals,
Inc., (the “Company”), and GHS Investments, LLC (the “Investor”).

 

Recitals

 

A.       The
Investor wishes to purchase from the Company and the Company wishes to sell and issue to the Investor, upon the terms and conditions
stated in this Agreement:

 

1.
$34,500 of Securities, in the form of a Convertible Promissory Note (the "Note"), attached hereto in accordance with
the following schedule:

 

Thirty
thousand dollars ($30,000) by wire transfer upon the Closing (as defined below).

 

In
consideration of the mutual promises made herein and for other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the parties hereto agree as follows:

 

1.                 
Definitions. In addition to those terms defined above and elsewhere in this Agreement, for the purposes of this Agreement,
the following terms shall have the meanings set forth below:

 

“Affiliate”
means, with respect to any Person, any other Person which directly or indirectly through one or more intermediaries Controls,
is controlled by, or is under common control with, such Person.

 

“Business
Day” means a day, other than a Saturday or Sunday, on which banks in New York City are open for the general transaction
of business. 

 

“Common
Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to
acquire at any time Common Stock, including without limitation, any debt, preferred stock, rights, options, warrants or other
instrument that is at any time convertible into or exchangeable for, or otherwise entitles the holder thereof to receive, Common
Stock.

 

“Company’s
Knowledge” means the actual knowledge of the executive officers (as defined in Rule 405 under the 1933 Act) of the Company,
after due inquiry.

 

“Confidential
Information” means trade secrets, confidential information and know-how (including but not limited to ideas, formulae,
compositions, processes, procedures and techniques, research and development information, computer program code, performance specifications,
support documentation, drawings, specifications, designs, business and marketing plans, and customer and supplier lists and related
information).

    	 	1	 

    	 	 	 

    

 

“Control”
(including the terms “controlling”, “controlled by” or “under common control with”) means
the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of a Person,
whether through the ownership of voting securities, by contract or otherwise.

 

“Intellectual
Property” means all of the following: (i) patents, patent applications, patent disclosures and inventions (whether or
not patentable and whether or not reduced to practice); (ii) trademarks, service marks, trade dress, trade names, corporate names,
logos, slogans and Internet domain names, together with all goodwill associated with each of the foregoing; (iii) copyrights and
copyrightable works; (iv) registrations, applications and renewals for any of the foregoing; and (v) proprietary computer software
(including but not limited to data, data bases and documentation).

 

“Material
Adverse Effect” means a material adverse effect on (i) the assets, liabilities, results of operations, condition (financial
or otherwise), business, or prospects of the Company and its Subsidiaries taken as a whole, or (ii) the ability of the Company
to perform its obligations under the Transaction Documents.

 

“Person”
means an individual, corporation, partnership, limited liability company, trust, business trust, association, joint stock company,
joint venture, sole proprietorship, unincorporated organization, governmental authority or any other form of entity not specifically
listed herein.

 

“Purchase
Price” means $30,000, representing a 10% original issuance discount on the Note and an initial $1,500 to offset transaction
costs.

 

“SEC”
means the United States Securities and Exchange
Commission.

 

“Securities”
means the Note and the common shares issuable at conversion.

 

“Subsidiary”
of any Person means another Person, an amount of the voting securities, other voting ownership or voting partnership interests
of which is sufficient to elect at least a majority of its Board of Directors or other governing body (or, if there are no such
voting interests, 50% or more of the equity interests of which) is owned directly or indirectly by such first Person.

 

“Transaction
Documents” means this Agreement, the Note, the Company Representation Letter,
and supporting documents.

 

“1933
Act” means the Securities Act of 1933, as amended, or any successor statute, and the rules and regulations promulgated
thereunder.

    	 	2	 

    	 	 	 

    

“1934
Act” means the Securities Exchange Act of 1934, as amended, or any successor statute, and the rules and regulations
promulgated thereunder.

 

2.                 
Purchase and Sale of the Securities. Subject to the terms and conditions of this Agreement, the Company shall sell and
issue to the Investor a Promissory Note in the principal amount of $34,500.00. 

 

2.1       Security
As Security for the Company's obligations contained herein and in all Notes issued
by the Company to the Holder, following any Event of Default which remains uncured
for thirty (30) calendar days, the Holder shall be granted an unconditional first priority interest in and to, any and all property
of the Company and its subsidiaries, of any kind or description, tangible or intangible, whether now existing
or hereafter arising or acquired until the balance of all Notes has been reduced to $0. "Any and all property,"
as described herein shall be inclusive of, but not limited to, assets reported by the Company on its SEC filings, cash, inventory,
accounts receivable, intellectual property rights, equipment and property. The Investor is authorized to make all filings the
Investor, in its discretion, deems necessary to evidence its security interests.

 

3.                 
Closing. Upon confirmation that the other conditions to closing specified herein have been satisfied or duly waived by
the Investor, the Company shall deliver to the Investor, a Note registered the name of the Investor and the Investor shall cause
a wire transfer in same day funds to be sent to the account of the Company as instructed in writing by the Company, in an amount
representing the Purchase Price for the Note (the “Closing Date”).

 

4.                 
Representations and Warranties of the Company. The Company hereby represents and warrants to the Investor that, except
as set forth in the schedules delivered herewith (collectively, the “Disclosure Schedules”) and as disclosed in the
Company’s SEC Filings:

 

4. 
1 Organization, Good Standing and Qualification. Each of the Company and its Subsidiaries is a corporation duly organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation and has all requisite corporate
power and authority to carry on its business as now conducted and to own its properties. Each of the Company and its Subsidiaries
is duly qualified to do business as a foreign corporation and is in good standing in each jurisdiction in which the conduct of
its business or its ownership or leasing of property makes such qualification or leasing necessary unless the failure to so qualify
has not and could not reasonably be expected to have a Material Adverse Effect. The Company’s Subsidiaries are listed on
the Company’s public disclosures filed with the SEC.

 

4.2             
Authorization. The Company has full power and authority and, has taken all requisite action on the part of the Company,
its officers, directors and stockholders necessary for (i) the authorization, execution and delivery of the Transaction Documents,
(ii) authorization of the performance of all obligations of the Company hereunder or thereunder, and (iii) the authorization,
issuance (or reservation for issuance) and delivery of the Securities. The Transaction Documents constitute the legal, valid and
binding obligations of the Company, enforceable against the Company in accordance with their terms, subject to bankruptcy, insolvency,
fraudulent transfer, reorganization, moratorium and similar laws of general applicability, relating to or affecting creditors’
rights generally.

    	 	3	 

    	 	 	 

    

 

4.3             
Capitalization. As of the date hereof, the authorized common stock of the Company on the date hereof is 2,010,000,000 the
number of shares of capital stock issued an doutstanding as of 11/3/17 is 995,027,821; (c) the number of shares of capital stock
issuable pursuant to the Company’s stock plans 30,000,000; and (d) the
number of shares of capital stock issuable and reserved for issuance pursuant to securities (other than the Securities) exercisable
for, or convertible into or exchangeable for any shares of capital stock of the Company as of 11/3/17 are 1,973,823,9.58
All of the issued and outstanding shares of the Company’s capital stock have been duly authorized and validly issued and
are fully paid, nonassessable and free of pre- emptive rights. All of the issued and outstanding shares of capital stock of each
Subsidiary have been duly authorized and validly issued and are fully paid, nonassessable and free of pre-emptive rights, were
issued in full compliance with applicable state and federal securities law and any rights of third parties and are owned by the
Company, beneficially and of record, subject to no lien, encumbrance or other adverse claim. No Person is entitled to pre-emptive
or similar statutory or contractual rights with respect to any securities of the Company. Other than described herein and in the
Company's periodic reports filed with the SEC, there are no outstanding warrants, options, convertible securities or other rights,
agreements or arrangements of any character under which the Company or any of its Subsidiaries is or may be obligated to issue
any equity securities of any kind and except as contemplated by this Agreement, neither the Company nor any of its Subsidiaries
is currently in negotiations for the issuance of any equity securities of any kind.

 

The
issuance and sale of the Securities hereunder will not obligate the Company to issue shares of Common Stock or other securities
to any other Person (other than the Investor) and will not result in the adjustment of the exercise, conversion, exchange or reset
price of any outstanding security.

 

The
Company does not have outstanding stockholder purchase rights or “poison pill” or any similar arrangement in effect
giving any Person the right to purchase any equity interest in the Company upon the occurrence of certain events.

 

4.4             
Valid Issuance. The issued Securities have been duly and validly authorized and, when issued and paid for pursuant to this
Agreement, shall be free and clear of all encumbrances and restrictions (other than those created by the Investor), except for
restrictions on transfer set forth in the Transaction Documents or imposed by applicable securities laws. Upon the due conversion
of the Debenture, the Converted Shares will be validly issued, fully paid and non-assessable free and clear of all encumbrances
and restrictions, except for restrictions on transfer set forth in the Transaction Documents or imposed by applicable securities
laws and except for those created by the Investor. The Company has reserved a sufficient number of shares of Common Stock for
issuance upon the exercise of the Debenture, free and clear of all encumbrances and restrictions, except for restrictions on transfer
set forth in the Transaction Documents or imposed by applicable securities laws and except for those created by the Investor.

    	 	4	 

    	 	 	 

    

 

4.5             
Consents. The execution, delivery and performance by the Company of the Transaction Documents, and the offer, issuance
and sale of the Securities require no consent of, action by or in respect of, or filing with, any Person, governmental body, agency,
or official other than filings that have been made pursuant to applicable state securities laws, and post-sale
filings pursuant to applicable state and federal securities laws which the Company undertakes to file within the applicable
time periods. Subject to the accuracy of the representations and warranties of the Investor set forth in Section 5 hereof, the
Company has taken all action necessary to exempt (i) the issuance and sale of the Securities, (ii) the issuance of the Shares
upon due conversion of the Debenture, and (iii) the other transactions contemplated by the Transaction Documents from the provisions
of any shareholder rights plan or other “poison pill” arrangement, any anti-takeover, business combination or control
share law or statute binding on the Company or to which the Company or any of its assets and properties may be subject and any
provision of the Company’s Articles of Incorporation or By-laws that is or could reasonably be expected to become applicable
to the Investor as a result of the transactions contemplated hereby, including without limitation, the issuance of the Securities
and the ownership, disposition or voting of the Securities by the Investor or the exercise of any right granted to the Investor
pursuant to this Agreement or the other Transaction Documents.

 

4.6             
Delivery of SEC Filings; Business. The Company has made available or shall make available, within twenty calendar days
from the execution of this Agreement, to the Investor through the EDGAR system, true and complete copies of the Company’s
most recent Annual Report on Form 10-K for its last fiscal year (the “10-K”), and all other reports filed by the Company
pursuant to the 1934 Act since the filing of the 10-K and prior to the date hereof (collectively, the “SEC Filings”).
The SEC Filings are the only filings required of the Company pursuant to the 1934 Act for such period. The Company and its Subsidiaries
are engaged in all material respects only in the business described in the SEC Filings and the SEC Filings contain a complete
and accurate description in all material respects of the business of the Company and its Subsidiaries, taken as a whole.

 

4.7             
Use of Proceeds. The net proceeds of the sale of the Note hereunder shall be used by the Company for working capital and
general corporate purposes. The Company agrees that it shall not use the funds from this Agreement, at any time, to lend money,
give credit or make advances to any officers, directors, employees, subsidiaries and affiliates of the Company.

 

4.8             
No Conflict, Breach, Violation or Default. The execution, delivery and performance of the Transaction Documents by the
Company and the issuance and sale of the Securities will not conflict with or result in a breach or violation of any of the terms
and provisions of, or constitute a default under (i) the Company’s Articles of Incorporation or the Company’s Bylaws,
both as in effect on the date hereof (true and complete copies of which have been made available to the Investor through the EDGAR
system), or (ii)(a) any statute, rule, regulation or order of any governmental agency or body or any court, domestic or foreign,
having jurisdiction over the Company, any Subsidiary or any of their respective assets or properties, or (b) any agreement or
instrument to which the Company or any Subsidiary is a party or by which the Company or a Subsidiary is bound or to which any
of their respective assets or properties is subject.

    	 	5	 

    	 	 	 

    

 

4.9             
Brokers and Finders. No Person will have, as a result of the transactions contemplated by the Transaction Documents, any
valid right, interest or claim against or upon the Company, any Subsidiary or an Investor for any commission, fee or other compensation
pursuant to any agreement, arrangement or understanding entered into by or on behalf of the Company.

 

4.10         
No Directed Selling Efforts or General Solicitation. Neither the Company nor any Person acting on its behalf has conducted
any general solicitation or general advertising (as those terms are used in Regulation D) in connection with the offer or sale
of any of the Securities.

 

4.11         
No Integrated Offering. Neither the Company nor any of its Affiliates, nor any Person acting on its or their behalf has,
directly or indirectly, made any offers or sales of any Company security or solicited any offers to buy any security, under circumstances
that would adversely affect reliance by the Company on Section 4(2) for the exemption from registration for the transactions contemplated
hereby or would require registration of the Securities under the 1933 Act.

 

4.12         
Private Placement. The offer and sale of the Securities to the Investor as contemplated hereby is exempt from the registration
requirements of the 1933 Act.

 

5.                 
Representations and Warranties of the Investor. The Investor hereby represents and warrants to the Company that:

 

5.1             
Organization and Existence. Such Investor is a validly existing corporation, limited partnership or limited liability company
and has all requisite corporate, partnership or limited liability company power and authority to invest in the Securities pursuant
to this Agreement.

 

5.2             
Authorization. The execution, delivery and performance by such Investor of the Transaction Documents to which such Investor
is a party have been duly authorized and will each constitute the valid and legally binding obligation of such Investor, enforceable
against such Investor in accordance with their respective terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization,
moratorium and similar laws of general applicability, relating to or affecting creditors’ rights generally.

 

5.3             
Purchase Entirely for Own Account. The Securities to be received by such Investor hereunder will be acquired for such Investor’s
own account, not as nominee or agent, and not with a view to the resale or distribution of any part thereof in violation of the
1933 Act, and such Investor has no present intention of selling, granting any participation in, or otherwise distributing the
same in violation of the 1933 Act without prejudice, however, to such Investor’s right at all times to sell or otherwise
dispose of all or any part of such Securities in compliance with applicable federal and state securities laws.  Nothing
contained herein shall be deemed a representation or warranty by such Investor to hold the Securities for any period of time.
Such Investor is not a broker-dealer registered with the SEC under the 1934 Act or an entity engaged in a business that would
require it to be so registered.

    	 	6	 

    	 	 	 

    

 

5.4             
Investment Experience. Such Investor acknowledges that it can bear the economic risk and complete loss of its investment
in the Securities and has such knowledge and experience in financial or business matters that it is capable of evaluating the
merits and risks of the investment contemplated hereby.

 

5.5             
Disclosure of Information. Such Investor has had an opportunity to receive all information related to the Company requested
by it and to ask questions of and receive answers from the Company regarding the Company, its business and the terms and conditions
of the offering of the Securities. Such Investor acknowledges receipt of copies of the SEC Filings. Neither such inquiries nor
any other due diligence investigation conducted by such Investor shall modify, amend or affect such Investor’s right to
rely on the Company’s representations and warranties contained in this Agreement.

 

5.6             
Restricted Securities. Such Investor understands that the Securities are characterized as “restricted securities”
under the U.S. federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public
offering and that under such laws and applicable regulations such securities may be resold without registration under the 1933
Act only in certain limited circumstances.

 

5.7             
Legends. It is understood that, except as provided below, certificates evidencing the Securities may bear the following
or any similar legend:

 

(a)              
“The securities represented hereby may not be transferred unless

(i)
such securities have been registered for sale pursuant to the Securities Act of 1933, as amended, (ii) such securities may be
sold pursuant to Rule 144(i), or (iii) the Company has received an opinion of counsel reasonably satisfactory to it that such
transfer may lawfully be made without registration under the Securities Act of 1933 or qualification under applicable state securities
laws.”

 

(b)              
If required by the authorities of any state in connection with the issuance of sale of the Securities, the legend required by
such state authority.

 

5.8             
Accredited Investor. Such Investor is an accredited investor as defined in Rule 501(a) of Regulation D, as amended, under
the 1933 Act.

 

5.9             
No General Solicitation. Such Investor did not learn of the investment in the Securities as a result of any public advertising
or general solicitation.

 

5.10         
Brokers and Finders. No Person will have, as a result of the transactions contemplated by the Transaction Documents, any
valid right, interest or claim against or upon the Company, any Subsidiary or an Investor for any commission, fee or other compensation
pursuant to any agreement, arrangement or understanding entered into by or on behalf of such Investor.

    	 	7	 

    	 	 	 

    

 

		6.	Conditions
                                         to Closing.

 

6.1             
Conditions to the Investor’s Obligations. The obligation of the Investor to purchase the Note at Closing is subject
to the fulfillment to such Investor’s satisfaction, on or prior to the Closing Date, of the following conditions, any of
which may be waived by the Investor:

 

(a)              
The representations and warranties made by the Company in Section 4 hereof qualified as to materiality shall be true and correct
at all times prior to and on the Closing Date, except to the extent any such representation or warranty expressly speaks as of
an earlier date, in which case such representation or warranty shall be true and correct as of such earlier date, and, the representations
and warranties made by the Company in Section 4 hereof not qualified as to materiality shall be true and correct in all material
respects at all times prior to and on the Closing Date, except to the extent any such representation or warranty expressly speaks
as of an earlier date, in which case such representation or warranty shall be true and correct in all material respects as of
such earlier date. The Company shall have performed in all material respects all obligations and conditions herein required to
be performed or observed by it on or prior to the Closing Date.

 

(b)              
The Company shall have obtained any and all consents, permits, approvals, registrations and waivers necessary or appropriate for
consummation of the purchase and sale of the Securities, and the consummation of the other transactions contemplated by the Transaction
Documents, all of which shall be in full force and effect.

 

(c)              
No judgment, writ, order, injunction, award or decree of or by any court, or judge, justice or magistrate, including any bankruptcy
court or judge, or any order of or by any governmental authority, shall have been issued, and no action or proceeding shall have
been instituted by any governmental authority, enjoining or preventing the consummation of the transactions contemplated hereby
or in the other Transaction Documents.

 

(d)              
The Company shall have executed and delivered the Convertible Note and supporting documentation.

 

(e)              
The Company shall have executed and delivered the Irrevocable Transfer Agent Instructions.

 

(f)               
No stop order or suspension of trading shall have been imposed by the public markets on which the Company’s common stock
is traded or quoted, the SEC or any other governmental or regulatory body with respect to public trading in the Common Stock.

 

6.2             
Conditions to Obligations of the Company. The Company's obligation to sell and issue the Note at Closing is subject to
the fulfillment to the satisfaction of the Company on or prior to the Closing Date of the following conditions, any of which may
be waived by the Company:

    	 	8	 

    	 	 	 

    

 

(a)              
The representations and warranties made by the Investor in Section 5 hereof, other than the representations and warranties contained
in Sections 5.3, 5.4, 5.5, 5.6, 5.7, 5.8 and 5.9 (the “Investment Representations”), shall be true and correct in
all material respects when made, and shall be true and correct in all material respects on the Closing Date with the same force
and effect as if they had been made on and as of said date. The Investment Representations shall be true and correct in all respects
when made, and shall be true and correct in all respects on the Closing Date with the same force and effect as if they had been
made on and as of said date. The Investor shall have performed in all material respects all obligations and conditions herein
required to be performed or observed by them on or prior to the Closing Date.

 

(b)              
The Investor shall have delivered the Purchase Price to the Company in accordance with the schedule outlined herein. 

 

		6.3	Termination
                                         of Obligations to Effect Closing; Effects.

 

(a)              
The obligations of the Company, on the one hand, and the Investor, on the other hand, to effect the Closing shall terminate as
follows:

 

(i)                
Upon the mutual written consent of the Company and the Investor;

 

(ii)              
By the Company if any of the conditions set forth in Section 6.2 shall have become incapable of fulfillment, and shall not have
been waived by the Company;

 

		(iii)	By
                                         the Investor if any of the conditions set forth in Section 6.1 shall have become incapable
                                         of fulfillment, and shall not have been waived by the Investor; orprovided, however,
                                         that, except in the case of clause (i) above, the party seeking to terminate its obligation
                                         to effect the Closing shall not then be in breach of any of its representations, warranties,
                                         covenants or agreements contained in this Agreement or the other Transaction Documents
                                         if such breach has resulted in the circumstances giving rise to such party’s seeking
                                         to terminate its obligation to effect the Closing.

		7.	Survival
                                         and Indemnification.

 

7.1     
Survival. The representations, warranties, covenants and agreements contained in this Agreement shall survive the Closing
of the transactions contemplated by this Agreement.

 

7.2  
Indemnification. The Company agrees to indemnify and hold harmless each Investor and its Affiliates and their respective
directors, officers, employees and agents from and against any and all losses, claims, damages, liabilities and expenses (including
without limitation reasonable attorney fees and disbursements and other expenses incurred in connection with investigating, preparing
or defending any action, claim or proceeding, pending or threatened and the costs of enforcement thereof) (collectively, “Losses”)
to which such Person may become subject as a result of any breach of representation, warranty, covenant or agreement made by or
to be performed on the part of the Company under the Transaction Documents, and will reimburse any such Person for all such amounts
as they are incurred by such Person.

    	 	9	 

    	 	 	 

    

 

7.3
Conduct of Indemnification Proceedings. Promptly after receipt by any Person (the “Indemnified
Person”) of notice of any demand, claim or circumstances which would or might give rise to a claim or the commencement of
any action, proceeding or investigation in respect of which indemnity may be sought pursuant to Section 7.2, such Indemnified
Person shall promptly notify the Company in writing and the Company shall assume the defense thereof, including the employment
of counsel reasonably satisfactory to such Indemnified Person, and shall assume the payment of all fees and expenses; provided,
however,that the failure of any Indemnified Person so to notify the Company shall not relieve the Company of its obligations
hereunder except to the extent that the Company is materially prejudiced by such failure to notify. In any such proceeding, any
Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense
of such Indemnified Person unless: (i) the Company and the Indemnified Person shall have mutually agreed to the retention of such
counsel; or (ii) in the reasonable judgment of counsel to such Indemnified Person representation of both parties by the same counsel
would be inappropriate due to actual or potential differing interests between them. The Company shall not be liable for any settlement
of any proceeding effected without its written consent, which consent shall not be unreasonably withheld, but if settled with
such consent, or if there be a final judgment for the plaintiff, the Company shall indemnify and hold harmless such Indemnified
Person from and against any loss or liability (to the extent stated above) by reason of such settlement or judgment. Without the
prior written consent of the Indemnified Person, which consent shall not be unreasonably withheld, the Company shall not affect
any settlement of any pending or threatened proceeding in respect of which any Indemnified Person is or could have been a party
and indemnity could have been sought hereunder by such Indemnified Party, unless such settlement includes an unconditional release
of such Indemnified Person from all liability arising out of such proceeding.

 

		8.	Miscellaneous.

 

8.1             
Successors and Assigns. This Agreement may not be assigned by a party hereto without the prior written consent of the Company
or the Investor, as applicable, provided, however, that an Investor may assign its rights and delegate its duties hereunder in
whole or in part to an Affiliate or to a third party acquiring some or all of its Securities in a private transaction without
the prior written consent of the Company, after notice duly given by such Investor to the Company. The provisions of this Agreement
shall inure to the benefit of and be binding upon the respective permitted successors and assigns of the parties. Nothing in this
Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors
and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided
in this Agreement.

    	 	10	 

    	 	 	 

    

8.2             
Counterparts; This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but
all of which together shall constitute one and the same instrument. This Agreement may also be executed via facsimile, which shall
be deemed an original.

 

8.3             
Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered
in construing or interpreting this Agreement.

 

8.4             
Notices. Unless otherwise provided, any notice required or permitted under this Agreement shall be given in writing and
shall be deemed effectively given as hereinafter described (i) if given by personal delivery, then such notice shall be deemed
given upon such delivery, (ii) if given by fax, then such notice shall be deemed
given upon receipt of confirmation of complete transmittal, (iii) if given by mail, then such notice shall be deemed given upon
the earlier of (A) receipt of such notice by the recipient or (B) three days after such notice is deposited in first class mail,
postage prepaid, and (iv) if given by an internationally recognized overnight air courier, then such notice shall be deemed given
one business day after delivery to such carrier. All notices shall be addressed to the party to be notified at the address as
follows, or at such other address as such party may designate by ten days’ advance written notice to the other party:

 

If
to the Company:

 

______________________

______________________

Attn:
__________________

Fax:
__________________

Tel:
__________________

 

 

If
to the Investor:

 

GHS
Investments, LLC

420
Jericho Turnpike, Suite 207

Jericho,
NY 11753 

 

8.5             
Expenses. The parties hereto shall pay their own costs and expenses in connection herewith. In the event that legal proceedings
are commenced by any party to this Agreement against another party to this Agreement in connection with this Agreement or the
other Transaction Documents, the party or parties which do not prevail in such proceedings shall severally, but not jointly, pay
their pro rata share of the reasonable attorneys’ fees and other reasonable out-of-pocket costs and expenses incurred by
the prevailing party in such proceedings.

    	 	11	 

    	 	 	 

    

 

8.6             
Amendments and Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement may
be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent
of the Company and the Investor. Any amendment or waiver effected in accordance with this paragraph shall be binding upon each
holder of any Securities purchased under this Agreement at the time outstanding, each future holder of all such Securities, and
the Company.

 

8.7             
Severability. Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such
jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions
hereof but shall be interpreted as if it were written so as to be enforceable to the maximum extent permitted by applicable law,
and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in
any other jurisdiction. To the extent permitted by applicable law, the parties hereby waive any provision of law which renders
any provision hereof prohibited or unenforceable in any respect.

 

8.8             
Entire Agreement. This Agreement, including the Exhibits and the Disclosure Schedules, and the other Transaction Documents
constitute the entire agreement among the parties hereof with respect to the subject matter hereof and thereof and supersede all
prior agreements and understandings, both oral and written, between the parties with respect to the subject matter hereof and
thereof.

 

8.9             
Further Assurances. The parties shall execute and deliver all such further instruments and documents and take all such
other actions as may reasonably be required to carry out the transactions contemplated hereby and to evidence the fulfillment
of the agreements herein contained.

 

8.10         
Governing Law; Consent to Jurisdiction; Waiver of Jury Trial. This Agreement shall be governed by, and construed in accordance
with, the internal laws of the State of Nevada, without regard to principles of conflicts of law. Each of the parties hereto irrevocably
submit to the exclusive jurisdiction of the state and federal courts sitting in New York
City, New York over any action or proceeding arising out of or relating to this Agreement and the parties hereto hereby irrevocably
agree that all claims in respect of such action or proceeding may be heard and determined in such court. The parties hereto agree
that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit
on the judgment or in any other manner provided by law. The parties hereto further waive any objection to venue in the State of
New York and any objection to an action or proceeding in the State of New York on the basis of forum non conveniens.

 

[signature
page follows]

    	 	12	 

    	 	 	 

    

 

IN
WITNESS WHEREOF, the parties have executed this Agreement or caused their duly authorized officers to execute this Agreement as
of the date first above written.

 

The
Company: Rich Pharmaceuticals, Inc.

 

 

By:
/s/ Ben Chang

Name:
Ben Chang

Title:
CEI

 

The
Investor: GHS Investments, LLC.

 

By:
/s/ Authorized Signatory

Member 

 

    	 	13	 

    	 	 	 

    

 

Disclosure
Schedules/ Exhibits

 

    	 	14NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES
REPRESENTED BY THIS NOTE NOR THE SECURITIES INTO WHICH
THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY
NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I)
IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION
STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, OR (B) AN OPINION OF COUNSEL
(WHICH COUNSEL SHALL BE SELECTED BY THE
HOLDER), IN A GENERALLY ACCEPTABLE FORM,
THAT REGISTRATION IS NOT REQUIRED UNDER SAID
ACT OR (II) UNLESS SOLD PURSUANTTORULE144ORRULE144AUNDERSAIDACT.
NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY
BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR
FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

 

 

Principal
Amount: $34,500 

Date: November
3, 2017

 

PROMISSORY
NOTE

 

Rich
Pharmaceuticals, Inc., (hereinafter called
the “Company”), hereby promises
to pay to the order of GHS
Investments, LLC, a Nevada Limited Liability Company,
or its registered assigns (the “Holder”) the sum of $34,500 on
August 3, 2018, (the "Maturity Date") together with any
interest as set forth herein, and
to pay interest on the unpaid principal
balance hereof at the rate of
ten percent (10%) (the “Interest
Rate”) per annum from the date
hereof (the “Issue Date”)
until the same becomes due and
payable, whether at maturity or upon acceleration
or by prepayment or otherwise. 

 

This
Note is being issued with a ten percent (10%) original issuance discount and with an initial $1,500 being withheld by the Holder
to offset transaction costs. 

 

This
Note may not be prepaid in whole or in part
except as otherwise explicitly set forth herein. Following any Event of Default,
all amounts owing pursuant to this Note shall bear interest at
the rate of twenty percent
(20%) per annum from the due date thereof
until the same is paid (“Default
Interest”). Interest shall be computed
on the basis of a 365-day year
and the actual number of days
elapsed. All payments due hereunder (to
the extent not converted into common stock)
shall be made in lawful money
of the United States of America.

 

All
payments shall be made at such address as
the Holder shall hereafter give to the
Company by written notice
made in accordance with the provisions
of this Note. Whenever any amount
expressed to be due by the terms
of this Note is due on any day which
is not a business day, the same shall instead
be due on the next succeeding
day which is a business day and, in
the case of any interest
payment date which is not the date on which this Note is paid
in full, the extension of the
due date thereof shall not be taken
into account for purposes of determining
the amount of interest due on such
date. As used in this Note, the term “business
day” shall mean any day other
than a Saturday, Sunday or a day on which
commercial banks in the city of New

    	 	1	 

    	 	 	 

    

York,
New York are authorized or required
by law or executive order to remain
closed. Each capitalized term used herein, and not otherwise defined, shall have the meaning ascribed thereto in the supporting
documents of same date (attached hereto).

 

This
Note is free from all taxes, liens, claims
and encumbrances with respect to the issue
thereof and shall not be subject to preemptive rights or other
similar rights of shareholders of the Company
and will not impose personal
liability upon the holder thereof.

 

The
following terms shall apply to this Note:

 

ARTICLE
I. CONVERSION
RIGHTS

 

1.1             
Conversion Right. The Holder shall have
the right and at any time following execution of this Note, to convert
all or any part of the outstanding
and unpaid principal amount of this Note into fully paid
and non- assessable shares of Common Stock, as such Common Stock exists on
the Issue Date, or any
shares of capital
stock or other securities of the Company
into which such Common Stock shall hereafter
be changed or reclassified at
the conversion price (the “Conversion Price”) determined as provided herein
(a “Conversion”); provided, however, that in no event shall
the Holder be entitled to convert
any portion of this Note in excess
of that portion of this Note upon conversion
of which the sum of (1) the number
of shares of Common Stock beneficially owned by the Holder
and its affiliates (other than shares of Common Stock which
may be deemed beneficially owned
through the ownership of the unconverted
portion of the Notes or the unexercised or unconverted
portion of any other security of the Company subject
to a limitation on conversion or exercise
analogous to the limitations contained herein) and (2) the number of
shares of Common Stock issuable
upon the conversion of the portion of this Note with respect
to which the determination of
this proviso is being made, would result
in beneficial ownership by the
Holder and its affiliates of more
than 4.99% of the outstanding shares of Common Stock. For
purposes of the proviso to the
immediately preceding sentence, beneficial ownership shall
be determined in accordance with
Section 13(d) of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”), and Regulations 13D-G
thereunder. The number of shares of
Common Stock to be issued upon each conversion
of this Note shall be determined
by dividing the Conversion Amount (as
defined below) by the applicable Conversion Price then in effect
on the date specified in the notice
of conversion, (the “Notice of Conversion”),
delivered to the Company by the
Holder in accordance with the Sections
below; provided that the Notice of Conversion
is submitted by facsimile
or e-mail (or by other
means resulting in, or reasonably expected to result
in, notice) to the Company before
6:00 p.m., New York, New York time on such
conversion date (the “Conversion Date”). Notwithstanding the foregoing, the term "4.99%" above shall
be replaced with "9.99%" following any Event of Default if the Holder, in its sole discretion and in writing, elects
to demand the replacement. If the term "4.99%" is replaced with "9.99%" pursuant to the preceding sentence,
such increase to "9.99%" shall remain at 9.99% until decreased by the Holder in writing.

 

The
number of shares of Common Stock to be
issued upon each conversion of this
Note shall be determined by
dividing the Conversion Amount (as defined
below) by the applicable Conversion Price
then in effect on the date specified
in the notice of conversion, (the “Notice
of Conversion”), delivered to the Company
by the Holder in accordance
with the Sections below.

 

The
term “Conversion Amount” means,
with respect to any conversion
of this Note, the sum of (1)  
the principal amount of this Note to be converted
in such conversion plus (2) at
the Company’s option, accrued and
unpaid interest, if any, on such principal
amount at the interest rates provided
in this Note to the Conversion Date,
plus (3) at the Company’s option,
Default Interest, if any, on the amounts
referred to in the immediately preceding clauses
(1) and/or (2) plus (4) at
the Holder’s option, any amounts owed
to the Holder.

    	 	2	 

    	 	 	 

    

 

		1.2	Conversion
                                         Price.

 

(a)               
Calculation of Conversion Price.Holder,
at its discretion, shall have the right to convert this Note in its entirety or in part(s) into common stock of the Company valued
at a forty percent (40%) discount off of the lowest intra-day trading price for the Company’s common stock during the ten
(10) trading days immediately preceding a conversion date, as reported by Quotestream Media.

 

If
at any time after the execution of this Note, the Company experiences a "DTC Chill," the Conversion Price Discount shall
be increased by five percent (5%). If at any time following the execution of this Note, the Company becomes ineligible to participate
in the DTC's "DWAC" system, the Conversion Price Discount will be increased by five percent (5%). Following any Event
of Default, the Conversion Price discount shall be permanently increased by ten percent (10%).

 

1.3             
Authorized Shares. The Company covenants
that during the period the conversion
right exists the Company will reserve
from its authorized and unissued
Common Stock a sufficient number of shares,
free from preemptive rights, to
provide for the issuance of Common Stock
upon the full conversion of this Note. The Company
is required at all times to have authorized and
reserved three times the number of shares
that is actually issuable upon full
conversion of the Note (based on the Conversion Price of the Notes
in effect from time to time)(the “Reserved
Amount”). The Reserved Amount shall
be increased from time to time in accordance
with the Company’s obligations.

 

The
Company represents that upon issuance,
such shares will be duly and validly issued, fully paid
and non-assessable. In addition, if
the Company shall issue any securities
or make any change to its capital
structure which would change the number of shares
of Common Stock into which the Notes
shall be convertible at the then current
Conversion Price, the Company shall at the same
time make proper provision so that thereafter
there shall be a sufficient number
of shares of Common Stock authorized and reserved,
free from preemptive rights, for conversion
of the outstanding Notes.

 

The
Company (i) acknowledges that
it will irrevocably instruct its transfer
agent to issue certificates for the Common Stock issuable
upon conversion of this Note, and (ii)
agrees that its issuance of this Note shall
constitute full authority to its officers and agents
who are charged with the duty of executing stock
certificates to execute and issue the necessary certificates
for shares of Common Stock in accordance
with the terms and conditions of this Note.

 

If,
at any time
the Company does not maintain
the Reserved Amount it will be considered
an Event of Default as defined in this Note.

 

		1.4	Method
                                         of
                                         Conversion.

    	 	3	 

    	 	 	 

    

(a)               
Mechanics of Conversion.
This Note may be converted by the Holder,
in whole or in part, at any time following
execution by submitting to the
Company a Notice of
Conversion (by facsimile,
e-mail or other reasonable means of communication
dispatched on the Conversion Date prior to 6:00 p.m., New York,
New York time).

 

(b)              
Surrender of
Note Upon Conversion.
Notwithstanding anything to the contrary set forth herein, upon conversion
of this Note in accordance with
the terms hereof, the Holder shall not
be required to physically surrender this Note to the
Company unless the entire unpaid principal
amount of this Note is so converted. The Holder and the Company shall
maintain records showing the principal amount so converted
and the dates of such conversions
or shall use such other method, reasonably
satisfactory to the Holder and the Company, so as
not to require physical surrender of this Note upon each
such conversion. In the event of any
dispute or discrepancy, such records of the Holder shall,
prima facie, be controlling and
determinative in the absence of manifest
error. The Holder and any assignee,
by acceptance of this Note,
acknowledge and agree that, by reason of the provisions
of this paragraph, following conversion
of a portion of this Note,
the unpaid and unconverted principal amount of this Note represented
by this Note may be less
than the amount stated on the face hereof.

 

(c)               
Payment of
Taxes.
The Company shall not be
required to pay any tax
which may be payable in respect
of any transfer involved in the issue
and delivery of shares
of Common Stock or other securities or property on conversion
of this Note in a name other than that
of the Holder (or in street name), and
the Company shall not be required
to issue or deliver any such shares
or other securities or property
unless and until the person or persons (other
than the Holder or the custodian
in whose street name such shares are to be held
for the Holder’s account) requesting the issuance thereof
shall have paid to the Company the amount
of any such tax or shall have established
to the satisfaction of the Company
that such tax has been paid.

 

(d)              
Delivery of
Common Stock Upon Conversion. Upon
receipt by the Company
from the Holder of a facsimile
transmission or e-mail (or other reasonable means of communication)
of a Notice of Conversion meeting
the requirements for conversion as provided in this Section,
the Company shall issue and
deliver or cause to be issued and delivered to or upon the order
of the Holder certificates for the Common Stock issuable
upon such conversion within three (3)
business days after such receipt (the “Deadline”) (and, solely
in the case of conversion of the entire
unpaid principal amount hereof, surrender of this Note) in accordance
with the terms hereof and the Purchase Agreement.

 

Within
Five (5) business days of having received common stock pursuant to a Notice of Conversion and prior to having traded any shares
from that specific conversion, Holder may elect to rescind the Notice of Conversion and return the shares, at Holder's expense,
to the Company's Transfer Agent. In the event of such rescission, the principal amount outstanding under this Note shall be adjusted
to include the Conversion Amount which was deducted from the Note as part of the rescinded Notice of Conversion.

 

(e)               
Obligation of Company
to Deliver Common Stock.
Upon receipt by the Company
of a Notice of Conversion, the Holder shall be deemed to be the holder
of record of the Common Stock issuable
upon such conversion, the outstanding principal
amount and the amount of accrued and
unpaid interest on this Note shall be reduced
to reflect such conversion, and, unless the Company
defaults on its obligations under
this Article I, all
rights with respect to the portion
of this Note being so converted shall forthwith terminate
except the right to receive the
Common Stock or other securities, cash or other
assets, as herein provided, on such
conversion. If the Holder shall
have given a Notice of
Conversion as provided herein, the Company’s
obligation to issue and deliver the certificates for Common Stock shall be absolute
and unconditional, irrespective of the
absence of any action by
the Holder to enforce the same, any
waiver or consent with respect to any
provision thereof, the recovery of any
judgment against any person
or any action to enforce the same, any
failure or delay in the enforcement of any other obligation of the Company
to the holder of record, or any setoff,
counterclaim, recoupment, limitation or termination, or any breach or alleged breach by
the Holder of any obligation
to the Company, and irrespective of any
other circumstance which might otherwise limit such obligation of the Company
to the Holder in connection with such conversion. The Conversion Date specified in
the Notice of Conversion shall be the Conversion Date so long as the Notice of Conversion is received by
the Company before
6:00 p.m., New York, New York time, on such date.

    	 	4	 

    	 	 	 

    

 

(f)               
Delivery of
Common Stock by Electronic Transfer.In
lieu of delivering physical certificates
representing the Common Stock issuable upon conversion,
provided the Company is participating in the Depository Trust Company (“DTC”)
Fast Automated Securities Transfer (“FAST”) program, upon request
of the Holder and its compliance
with the provisions contained in Section 1.1 and
in this Section 1.4, the Company shall use its best
efforts to cause its transfer
agent to electronically transmit the Common
Stock issuable upon conversion to the Holder
by crediting the account of Holder’s
Broker with DTC through its Deposit
Withdrawal Agent Commission (“DWAC”) system.

 

(g)  
Failure to Deliver Common Stock Prior
to Deadline.
Without in any way limiting the Holder’s
right to pursue other remedies, including actual damages and/or equitable relief,
the parties agree that if delivery of the Common Stock issuable
upon conversion of this Note is not delivered
by the Deadline the Company shall
pay to the Holder $2,000 per day in cash,
for each day beyond
the Deadline that the Company fails to deliver
such Common Stock. Such cash amount shall be paid
to Holder by the fifth
day of the month following the
month in which it has accrued or, at
the option of the Holder (by written notice
to the Company by the first day
of the month following the month in which
it has accrued), shall be added to the principal
amount of this Note, in which event
interest shall accrue thereon in accordance
with the terms of this Note and such
additional principal amount shall be convertible into Common Stock in accordance
with the terms of this Note.
The Company agrees that the right to
convert is a valuable right to the Holder.
The damages resulting from a failure,
attempt to frustrate, interference with such
conversion right are difficult if not impossible to qualify.Accordingly
the parties acknowledge that the liquidated
damages provision contained in this Section are justified. Any delay or failure
of performance by the Company hereunder shall be excused if and to the extent caused by Force Majeure. For purposes of this agreement,
Force Majeure shall mean a cause or event that is not reasonably foreseeable and not caused by the Company, including acts of
God, fires, floods, explosions, riots wars, hurricanes, etc.

 

1.5             
Concerning the Shares. The shares
of Common Stock issuable upon conversion
of this Note may not be sold or transferred
unless (i) such shares are sold pursuant to an effective registration statement under
the Act or (ii) the Company
or its transfer agent shall
have been furnished with an opinion
of counsel (which opinion shall be in
form, substance and scope customary for
opinions of counsel in comparable transactions)
to the effect that the shares
to be sold or transferred may be sold or transferred pursuant
to an exemption from such registration
or (iii) such shares are sold or
transferred pursuant to Rule 144 under
the Act (or a successor rule) (“Rule
144”) or (iv) such shares are
transferred to an “affiliate” (as defined in Rule 144) of the
Company who agrees to sell
or otherwise transfer the shares only in accordance
with this Section 1.5 and who
is an Accredited Investor. Except as otherwise
provided herein (and subject to the removal
provisions set forth below), until such time as the shares of Common Stock
issuable upon conversion of
this Note have been registered under the Act
or otherwise may be sold pursuant
to Rule 144 without any restriction as to the number
of securities as of a particular date
that can then be immediately
sold, each certificate for shares of
Common Stock issuable upon conversion of this Note that has
not been so included in an
effective registration statement or that
has not been sold pursuant to
an effective registration statement or an
exemption that permits removal of the legend,
shall bear a legend substantially in the following
form, as appropriate:

    	 	5	 

    	 	 	 

    

 

“NEITHERTHEISSUANCEANDSALEOFTHESECURITIES
REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICHTHESESECURITIESAREEXERCISABLEHAVEBEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR
SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE
REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE
SELECTED BY THEHOLDER),INAGENERALLYACCEPTABLEFORM,THAT
REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144
OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE
PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER
LOAN OR FINANCING ARRANGEMENT SECURED BY
THE SECURITIES.”

 

The
legend set forth above shall be removed
and the Company shall issue to the Holder
a new certificate therefore free of any
transfer legend if (i) the Company
or its transfer agent shall have received an
opinion of counsel, in form, substance and scope customary for opinions of
counsel in comparable transactions,
to the effect that a public sale or transfer
of such Common Stock may be made
without registration under the Act,
which opinion shall be accepted
by the Company so that the sale
or transfer is effected or (ii)
in the case of the Common Stock issuable upon conversion
of this Note, such security is registered
for sale by the Holder under an effective
registration statement filed under the Act or otherwise may
be sold pursuant to Rule 144 without any
restriction as to the number
of securities as of a particular date that
can then be immediately sold.In the
event that the Company does not
accept the opinion of counsel provided
by the Buyer with respect to the transfer
of Securities pursuant to an
exemption from registration, such as Rule 144 or Regulation S, at
the Deadline, it will be considered
an Event of Default pursuant to
this note.

 

		1.6	Effect
                                         of
                                         Certain
                                         Events.

 

(a)               
Effect of Merger, Consolidation, Etc.
At the option of the Holder, the sale,
conveyance or disposition of all or substantially
all of the assets of the Company,
the effectuation by the Company of a
transaction or series of related transactions
in which more than 50% of the voting power of the Company
is disposed of, or the consolidation,
merger or other business combination of the Company
with or into any other Person (as defined
below) or Persons when the Company
is not the survivor shall either: (i) be deemed to be an
Event of Default (as defined in Article III)
pursuant to which the Company
shall be required to pay to the Holder
upon the consummation of and as a condition
to such transaction an amount equal
to the Default Amount (as defined
in Article III) or (ii)
be treated pursuant to Section 1.6(b)
hereof. “Person” shall mean any individual,
corporation, limited liability company,
partnership, association, trust or other entity or organization.

    	 	6	 

    	 	 	 

    

 

(b)               
Adjustment Due to Merger,
Consolidation, Etc.
If, at any
time when this Note is issued and outstanding
and prior to conversion of all
of the Notes, there shall be any merger,
consolidation, exchange of shares, recapitalization, reorganization,
or other similar event, as a result
of which shares of Common Stock of the Company shall be changed into the same
or a different number of
shares of another
class or classes of stock or securities
of the Company or another entity, or in case
of any sale or conveyance of
all or substantially all of the assets
of the Company other than in connection with a plan
of complete liquidation of the Company, then
the Holder of this Note shall thereafter have
the right to receive upon conversion
of this Note, upon the basis and
upon the terms and conditions specified herein
and in lieu of the shares
of Common Stock immediately theretofore issuable
upon conversion, such stock, securities or assets
which the Holder would have been entitled
to receive in such
transaction had this Note been converted in full
immediately prior to such transaction (without regard
to any limitations on conversion
set forth herein), and in any such case appropriate
provisions shall be made with respect
to the rights and interests of the Holder
of this Note to the end that the
provisions hereof (including, without limitation,
provisions for adjustment of the Conversion Price and of the number of shares
issuable upon conversion of the Note)
shall thereafter be applicable, as nearly as
may be practicable in relation
to any securities or assets thereafter deliverable
upon the conversion hereof. The Company shall not affect
any transaction described in this Section
1.6(b) unless (a) it first gives, to
the extent practicable, thirty (30) days prior
written notice (but in any event at
least fifteen (15) days prior written
notice) of the record date of the special meeting of shareholders
to approve, or if there is no such record date, the consummation
of, such merger, consolidation, exchange
of shares, recapitalization, reorganization
or other similar event or sale
of assets (during which time the Holder
shall be entitled to convert
this Note) and (b) the resulting successor
or acquiring entity (if not the Company) assumes
by written instrument the obligations
of this Section 1.6(b). The above provisions
shall similarly apply to successive consolidations, mergers,
sales, transfers or share exchanges.

 

(c)          
Adjustment Due to Distribution. If
the Company
shall declare or make
any distribution of its assets (or rights to acquire its assets) to holders of Common Stock as a dividend, stock repurchase,
by way
of return of capital
or otherwise (including any
dividend or distribution
to the Company’s
shareholders in cash
or shares (or rights to acquire shares) of capital stock of a subsidiary (i.e., a spin-off)) (a “Distribution”), then
the Holder of this Note shall be entitled, upon any conversion of this Note after the date of record for determining shareholders
entitled to such Distribution, to receive the amount of
such assets which would
have been payable to the Holder with respect to the shares of Common Stock issuable upon such conversion had such Holder been
the holder of such shares of Common Stock on the record date for the determination of shareholders entitled to such Distribution.

 

(d)              
Adjustment Due to Dilutive Issuance. If, at any time when any Notes issued under the Securities Purchase Agreement of even
date herewith are issued and outstanding, the Company issues or sells, or in accordance with this Section 1.6(d) hereof is deemed
to have issued or sold, any shares of Common Stock in connection with a financing transaction based on a variable price formula
(the “Alternative Variable Price Formula”) that is more favorable to the investor in such financing transaction than
the formula for calculating the Conversion Price in effect on the date of such issuance (or deemed issuance) of such shares of
Common Stock (a “Dilutive Issuance”), then immediately upon the Dilutive Issuance, the formula for the Conversion
Price will be adjusted to match the Alternative Variable Price Formula. If it is unclear whether the Alternative Variable Price
Formula is better or worse, then Holder, in its sole discretion, may elect at the time of such issuance whether to switch to the
Alternative Variable Price Formula or not.

    	 	7	 

    	 	 	 

    

 

(e)               
Purchase Rights. If,
at any time when any
Notes are issued and
outstanding, the Company
issues any convertible
securities or rights to purchase stock, warrants, securities or other property (the “Purchase Rights”) pro rata to
the record holders of any class of Common Stock, then the Holder of this Note will be entitled to acquire, upon the terms applicable
to such Purchase Rights, the aggregate Purchase Rights which such Holder could have acquired if such Holder had held the number
of shares of Common Stock acquirable upon complete conversion of this Note (without regard to any limitations on conversion contained
herein) immediately before the date on which a record is taken for the grant, issuance or
sale of such Purchase
Rights or, if no such record is taken, the date as of which the record holders of Common Stock are to be determined for the grant,
issue or sale of such Purchase Rights.

 

(f)               
Notice of Adjustments. Upon the occurrence of
each adjustment or readjustment
of the Conversion Price as a result of the events described in this Section 1.6, the Company,
at its expense, shall
promptly compute such adjustment or readjustment and prepare and furnish to the Holder of a certificate setting forth such adjustment
or readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The Company
shall, upon the written
request at any time of the Holder, furnish to such Holder a like certificate setting forth (i) such adjustment or readjustment,
(ii) the Conversion Price at the time in effect and (iii) the number of shares of Common Stock and the amount, if any, of other
securities or property which at the time would be received upon conversion of the Note.

 

1.7             
Security As Security for the Company's
obligations contained herein and in all Notes issued by the Company to the Holder, following any Event of Default which
remains uncured for thirty (30) calendar days, the Holder shall be granted an unconditional first priority interest in
and to, any and all property of the Company and its subsidiaries, of any kind or description, tangible or intangible, whether
now existing or hereafter arising or acquired until the balance of all Notes has
been reduced to $0. "Any and all property," as described herein shall be inclusive of, but not limited to, assets reported
by the Company on its SEC filings, cash, inventory, accounts receivable, intellectual property rights, equipment and or property.
The Investor is authorized to make all filings the Investor, in its discretion, deems necessary to evidence its security interests.

 

1.8             
Status as Shareholder. Upon submission
of a Notice of Conversion by a Holder,
(i) the shares covered thereby (other than the shares,
if any, which cannot be issued
because their issuance would exceed
such Holder’s allocated portion of the Reserved
Amount or Maximum Share Amount) shall
be deemed converted into shares
of Common Stock and (ii) the Holder’s
rights as a Holder of such
converted portion of this Note shall cease and terminate, excepting only the
right to receive certificates for such
shares of Common Stock and to any remedies
provided herein or otherwise available at law or in equity to such Holder
because of a failure by the Company
to comply with the terms of this Note. Notwithstanding
the foregoing, if a Holder has not received certificates
for all shares of Common Stock prior to the tenth
(10th) business day after the expiration
of the Deadline with respect to a conversion of any portion
of this Note for any reason, then (unless
the Holder otherwise elects to retain its status
as a holder of Common Stock by so notifying the Company) the Holder
shall regain the rights of a Holder
of this Note with respect to such unconverted
portions of this Note and the Company shall,
as soon as practicable, return such unconverted Note to the Holder
or, if the Note has not been surrendered, adjust its records
to reflect that such portion of
this Note has not been converted. In
all cases, the Holder shall retain
all of its rights and remedies (including, without limitation,
(i) the right to receive Conversion
Default Payments pursuant to Section
1.3 to the extent required thereby for
such Conversion Default and any
subsequent Conversion Default and (ii)
the right to have the Conversion
Price with respect to subsequent conversions
determined in accordance with Section
1.3) for the Company’s failure to convert
this Note.

    	 	8	 

    	 	 	 

    

 

1.9             
Prepayment. Maker may prepay this Note, in accordance with the following schedule:
If within 60 calendar days from the execution of this Note, 120% of all outstanding principal and interest due on each outstanding
Note in one payment; After 60 calendar days from the execution of the note and within 120 days from execution, 130% of all outstanding
principal and interest due on each outstanding Note in one payment. Between 121 and 180 days from the date of execution, the Note
may be prepaid for 135% of all outstanding amounts due on each outstanding Note in one payment. 

 

ARTICLE
II. CERTAIN
COVENANTS

 

2.1             
Distributions on Capital Stock.
So long as the Company shall
have any obligation under this
Note, the Company shall not without the
Holder’s written consent (a) pay,
declare or set apart for such payment,
any dividend or other distribution (whether
in cash, property or other securities)
on shares of capital
stock other than dividends on shares
of Common Stock solely in the form
of additional shares of Common Stock or (b)
directly or indirectly or through any
subsidiary make any other payment
or distribution in respect of its capital
stock except for distributions pursuant to any shareholders’ rights plan
which is approved by a majority of the Company’s
disinterested directors.

 

2.2             
Restriction on Stock Repurchases.
So long as the Company shall
have any obligation under this Note,
the Company shall not without the Holder’s
written consent redeem, repurchase
or otherwise acquire (whether for cash
or in exchange for property or other
securities or otherwise) in any one transaction
or series of related transactions
any shares of
capital stock of the Company or
any warrants, rights or options to purchase
or acquire any such shares. 

 

2.3             
Borrowings. So long as the Issuer
shall have any obligation under this
Note, the Issuer shall not, without providing
the Holder with written notice,
create, incur, assume guarantee, endorse, contingently agree to purchase
or otherwise become liable upon
the obligation of any person, firm,
partnership, joint venture or corporation, except
by the endorsement of negotiable
instruments for deposit or collection, or
suffer to exist

any
liability for borrowed money, except (a) borrowings in existence
or committed on the date hereof and
of which the Issuer has
informed Holder in writing prior to the date hereof, (b) indebtedness to trade
creditors or financial institutions incurred
in the ordinary course of business or (c)
borrowings, the proceeds of which shall
be used to repay this Note. 

 

2.4             
Sale of Assets. So long as
the Company shall have any
obligation under this Note, the
Company shall not, without the Holder’s
written consent, sell, lease or otherwise
dispose of any significant portion
of its assets outside the ordinary course of business.
Any consent to the disposition
of any assets may be conditioned on a
specified use of the proceeds of disposition.

    	 	9	 

    	 	 	 

    

2.5             
Advances and Loans. So long as the
Company shall have any
obligation under this Note, the
Company shall not, without the
Holder’s written consent, lend money, give credit
or make advances to any person, firm,
joint venture or corporation, including,
without limitation, officers, directors, employees, subsidiaries and affiliates
of the Company, except loans, credits
or advances (a) in existence or committed
on the date hereof and which the Company
has informed Holder in writing prior
to the date hereof, (b) made in the ordinary course
of business or (c) not in excess
of $50,000.

 

ARTICLE
III. EVENTS
OF DEFAULT

 

If
any of
the following events of default (each,
an “Event of Default”) shall
occur:

 

3.1             
Failure to Pay Principal or
Interest.The Company
fails to pay the principal
hereof or interest thereon when due on this Note,
whether at maturity, upon acceleration or otherwise.

 

3.2             
Conversion and the Shares.The
Company fails to issue shares of Common
Stock to the Holder (or announces or threatens
in writing that it will not honor its obligation to do so) upon exercise
by the Holder of the conversion
rights of the Holder in accordance with the terms of this Note,
fails to transfer or cause its
transfer agent to transfer (issue) (electronically
or in certificated form) any certificate for
shares of Common Stock issued to the Holder
upon conversion of or otherwise pursuant to this Note as
and when required by this Note, the Company
directs its transfer agent not
to transfer or delays, impairs, and/or hinders
its transfer agent in transferring (or
issuing) (electronically or in certificated form) any certificate
for shares of Common Stock to be issued to the Holder
upon conversion of or otherwise pursuant
to this Note as and when required by
this Note, or fails to remove (or directs
its transfer agent not to remove or
impairs, delays, and/or hinders its transfer
agent from removing) any restrictive legend (or to withdraw any stop transfer
instructions in respect thereof) on any certificate
for any shares of Common Stock issued
to the Holder upon conversion
of or otherwise pursuant to this Note as and when required by this Note (or
makes any written announcement, statement
or threat that it does not intend
to honor the obligations described in this paragraph) and
any such failure shall continue uncured (or
any written announcement, statement or threat
not to honor its obligations shall not be rescinded
in writing) for three (3) business days
after the Holder shall have delivered a Notice of Conversion.
It is an obligation of the Company
to remain current in its obligations
to its transfer agent. It shall
be an event of default of this Note,
if a conversion of this Note is delayed,
hindered or frustrated due to a balance
owed by the Company to its transfer agent. If
at the option of the Holder,
the Holder advances any funds to the
Company’s transfer agent in order
to process a conversion, such advanced funds
shall be paid by the Company to
the Holder within forty eight (48) hours
of a demand from the Holder.

 

3.3             
Breach of Covenants.
The Company breaches any covenant
or other term or
condition contained in this Note and
any collateral documents including
but not limited to the Purchase Agreement.

 

3.4             
Breach of Representations and Warranties.Any
representation or warranty of the Company
made herein or in any agreement, statement
or certificate given in

writing
pursuant hereto or in connection
herewith (including, without limitation,
the Purchase Agreement), shall be false or misleading
in any material respect when made and
the breach of which has (or with
the passage of time will have) a material adverse effect on the rights of the Holder
with respect to this Note or the Purchase Agreement.

    	 	10	 

    	 	 	 

    

3.5             
Receiver or Trustee.
The Company or any subsidiary of
the Company shall make an assignment for
the benefit of creditors, or apply for or consent to the appointment
of a receiver or trustee for it
or for a substantial part of its property
or business, or such a receiver or trustee
shall otherwise be appointed.

 

3.6             
Judgments. Any money judgment, writ
or similar process shall be entered or
filed against the Company or
any subsidiary of the Company or any
of its property or other assets for more than $50,000, and
shall remain unvacated, unbonded or unstayed for a period of twenty (20)
days unless otherwise consented to by
the Holder, which consent will not be unreasonably withheld.

 

3.7             
Bankruptcy. Bankruptcy, insolvency, reorganization or liquidation
proceedings or other proceedings,
voluntary or involuntary, for relief under
any bankruptcy law or any law for the
relief of debtors shall be instituted
by or against the Company or any subsidiary
of the Company.

 

3.8             
Delisting of Common Stock.
The Company shall within twenty calendar days from the execution of this Note,
fail to maintain in good standing the
listing of the Common Stock on the OTC Bulletin
Board or an equivalent replacement exchange, the Nasdaq National
Market, the Nasdaq SmallCap Market or the New
York Stock Exchange.

 

3.9             
Failure to Comply with the Exchange
Act. The Company shall fail
to comply, within twenty calendar days from the execution of this Note, with the reporting
requirements of the Exchange Act; and/or the Company shall
cease to be subject to the reporting
requirements of the Exchange Act.

 

3.10         
Liquidation. Any dissolution, liquidation,
or winding up of Company or any substantial
portion of its business.

 

3.11         
Cessation of Operations. Any cessation of operations by
Company or Company admits it is
otherwise generally unable to pay its
debts as such debts become due, provided, however,
that any disclosure of the Company’s
ability to continue as a “going concern”
shall not be an admission that the Company
cannot pay its debts as they
become due.

 

3.12         
Maintenance of Assets.
The failure by Company
to maintain any material intellectual
property rights, personal, real property or other
assets which are necessary to conduct its business
(whether now or in the future).

 

3.13         
Financial Statement Restatement.The restatement
of any financial statements filed
by the Company with the SEC for any date
or period from two years prior to the Issue
Date of this Note and until this Note is no longer
outstanding, if the result of such restatement
would, by comparison to the original
financial statement, have constituted a material
adverse effect on the rights of the Holder with respect
to this Note or supporting documents.

 

3.14         
Reverse Splits. The Company effectuates
a reverse split of its Common Stock
without at least twenty (20) days prior written notice
to the Holder.

 

3.15
         Replacement of Transfer
Agent. In the event
that the Company proposes
to replace its
transfer agent, the Company fails
to provide, prior to the effective
date of such replacement, a fully executed
Irrevocable Transfer Agent Instructions in a form
as initially delivered pursuant to the Purchase
Agreement (including but not limited to the provision
to irrevocably reserve shares of Common Stock in the
Reserved Amount) signed by the successor
transfer agent to Company and
the Company.

    	 	11	 

    	 	 	 

    

 

3.16         
Cross-Default. Notwithstanding anything to the contrary contained
in this Note or the other related or companion
documents, a breach or default
by the Company of any
covenant or other term or
condition contained in any of the Other
Agreements, after the passage of all
applicable notice and cure or grace periods, shall,
at the option of the Holder, be
considered a default under this Note
and the Other Agreements, in which
event the Holder shall be entitled (but
in no event required) to apply all rights
and remedies of the Holder under the terms
of this Note and the Other Agreements
by reason of a default under said
Other Agreement or hereunder.“Other Agreements” means, collectively,
all agreements and instruments between, among or
by: (1) the Company, and, or
for the benefit of, (2) the Holder
and any affiliate of the Holder,
including, without limitation, promissory notes;
provided, however, the term “Other
Agreements” shall not include
the related or companion documents to
this Note. Each of the loan transactions will
be cross-defaulted with each other loan transaction
and with all other existing and future
debt of Company.Upon the occurrence
and during the continuation of
any Event of Default specified
in Section 3.1 (solely with respect
to failure to pay the principal hereof
or interest thereon when due at
the Maturity Date), the Note shall become
immediately due and payable and the
Company shall pay
to the Holder, in full satisfaction of
its obligations hereunder, an amount
equal to the Default Sum (as
defined herein).

 

UPON
THE OCCURRENCE AND DURING THE CONTINUATION OF
ANY EVENT OF DEFAULT SPECIFIED
IN SECTION 3.2, THE NOTE SHALL
BECOME IMMEDIATELY DUE AND PAYABLE AND
THE COMPANY SHALL PAY TO THE HOLDER, IN
FULL SATISFACTION OF ITS OBLIGATIONS
HEREUNDER, AN AMOUNT EQUAL TO: (Y) THE
DEFAULT SUM (AS DEFINED HEREIN); MULTIPLIED BY (Z) TWO (2). Upon the occurrence and during
the continuation of any Event of Default
specified in Sections 3.1 (solely with respect to failure to pay the
principal hereof or interest thereon when due on this Note upon a Trading Market Prepayment Event pursuant to Section 1.7 or
upon acceleration), 3.3, 3.4, 3.6, 3.8, 3.9, 3.11, 3.12, 3.13, 3.14, and/or

 

3.
15 exercisable through the delivery of written notice to the Company by
such Holders (the “Default Notice”), and upon the occurrence of an Event
of Default specified the remaining sections of Articles III (other than failure to pay the principal hereof or interest thereon
at the Maturity Date specified in Section 3,1 hereof), the Note shall become immediately due and payable and the Company
shall pay to the Holder, in full satisfaction of its obligations hereunder, an amount
equal to 150% times the sum of (w) the then outstanding principal amount of this Note plus (x) accrued and
unpaid interest on the unpaid principal amount of this Note to the date of payment (the “Mandatory Prepayment Date”)
plus (y) Default Interest, if any, on the amounts referred to in clauses (w) and/or (x) plus (z) any amounts owed
to the Holder pursuant to Sections 1.3 and 1.4(g) hereof (the then outstanding principal amount of this Note to the date
of payment plus the amounts referred
to in clauses (x), (y) and (z) shall collectively be known as the “Default Sum”) .

 

If the Company fails to
pay the Default Amount within five (5)
business days of written notice that
such amount is due and payable, then the Holder shall have
the right at any time,
so long as the Company remains
in default (and so long and to the
extent that there are sufficient authorized shares), to require
the Company, upon written notice, to
immediately issue, in lieu of the
Default Amount, the number of shares of
Common Stock of the Company equal to
the Default Amount divided by the
Conversion Price then in effect.

    	 	12	 

    	 	 	 

    

 

ARTICLE
IV. MISCELLANEOUS

 

4.1             
Failure or Indulgence Not
Waiver. No failure or
delay on the part of the Holder
in the exercise of any power, right or
privilege hereunder shall operate as
a waiver thereof, nor shall any single
or partial exercise of any such
power, right or privilege preclude other or further
exercise thereof or of any other
right, power or privileges.All rights
and remedies existing hereunder are cumulative to, and
not exclusive of, any rights or remedies
otherwise available.

 

4.2             
Notices. All notices, demands, requests,
consents, approvals, and other communications
required or permitted hereunder shall be in writing
and, unless otherwise specified herein, shall be (i)
personally served, (ii) deposited in the mail, registered
or certified, return receipt requested,
postage prepaid, (iii) delivered by
reputable air courier service with charges
prepaid, or (iv) transmitted by
hand delivery, telegram, or facsimile, addressed
as set forth below or to such
other address as such party shall have
specified most recently by written notice.
Any notice or other communication
required or permitted to be given
hereunder shall be deemed
effective (a) upon hand delivery or
delivery by facsimile, with accurate
confirmation generated by the transmitting facsimile
machine, at the address or number designated
below (if delivered on a business
day during normal business hours
where such notice is to be received),
or the first business day
following such delivery (if delivered other than
on a business day during

normal
business hours where such notice is to be received)
or (b) on the second business
day following the date
of mailing by express
courier service, fully prepaid, addressed to such
address, or upon actual receipt
of such mailing, whichever shall first occur.
The addresses for such communications shall be:

 

If
to the Company,
to:

 

________________ 

________________ 

________________  

 

 

If
to the Holder:

 

GHS
Investments, LLC.

420
Jericho Turnpike

Suite
207

Jericho,
NY 11753

 

4.3             
Amendments. This Note and any
provision hereof may only be amended
by an instrument in writing
signed by the Company and the Holder.
The term “Note” and all reference
thereto, as used throughout this
instrument, shall mean this instrument (and
the other Notes issued pursuant to the Purchase
Agreement) as originally executed, or if later
amended or supplemented, then as so amended
or supplemented.

 

4.4             
Assignability. This Note shall be
binding upon the Company and its successors
and assigns, and shall inure to be the benefit
of the Holder and its successors and
assigns. Notwithstanding anything in this Note to the contrary, this Note may be pledged
as collateral in connection with a bona fide
margin account or other lending
arrangement.

    	 	13	 

    	 	 	 

    

4.5             
Cost of Collection. If
default is made in the payment
of this Note, the Company
shall pay the Holder hereof costs
of collection, including reasonable attorneys’
fees.

 

4.6             
Governing Law.This Note shall
be governed by
and construed in accordance
with the laws of the State of Nevada without regard
to principles of conflicts of
laws.Any action brought by
either party against the other
concerning the transactions contemplated by
this Note shall be brought only
in the state or federal courts located
in the County, City and State of New York. The parties to this Note
hereby irrevocably waive any objection
to jurisdiction and venue of any action
instituted hereunder and shall not assert any
defense based on lack of jurisdiction
or venue or based upon forum
non conveniens. The Company and
Holder waive trial by jury.
The prevailing party shall be
entitled to recover from the other
party its reasonable attorney's fees and costs. In the event that
any provision of this Note or any other agreement
delivered in connection herewith is invalid
or unenforceable under any applicable
statute or rule of law, then such provision
shall be deemed inoperative to the extent that
it may conflict therewith and shall be deemed
modified to conform with such statute
or rule of law. Any such provision
which may prove invalid or unenforceable
under any law shall not affect
the validity or enforceability of any other provision of any
agreement. Each party hereby irrevocably waives
personal service of process and consents to process
being served in any suit, action
or proceeding in connection with this Agreement
or any other Transaction Document
by mailing a copy thereof via registered
or certified mail or overnight
delivery (with evidence of delivery)
to such party at the address
in effect for notices to it under
this Agreement and agrees that such service shall
constitute good and sufficient service of process
and notice thereof. Nothing contained herein shall be deemed
to limit in any way any right
to serve process in any other manner permitted by
law.

 

4.7             
Certain Amounts.Whenever
pursuant to this Note the Company is required
to pay an amount in excess of
the outstanding principal amount (or the portion
thereof required to be paid at that time)
plus accrued and unpaid interest
plus Default Interest on such interest,
the Company and the Holder agree that
the actual damages to the Holder from
the receipt of cash payment on this
Note may be difficult to determine and
the amount to be so paid by the Company
represents stipulated damages and not a penalty and
is intended to compensate the Holder
in part for loss of the opportunity to convert this Note and
to earn a return from the sale
of shares of Common Stock acquired upon
conversion of this Note at a price
in excess of the price paid for such
shares pursuant to this Note.
The Company and the Holder hereby agree
that such amount of stipulated damages is not plainly disproportionate
to the possible loss to the Holder from the receipt
of a cash payment without the opportunity to convert
this Note into shares of Common Stock.

 

4.8             
Purchase Agreement. By its acceptance of this Note,
each party agrees to be bound by
the applicable terms of the Securities Purchase Agreement
and supporting documents .

 

4.9              Notice
of Corporate Events. Except as
otherwise provided below, the Holder of this Note shall have
no rights as a Holder of Common Stock unless
and only to the extent that
it converts this Note into Common Stock. The Company shall provide the Holder
with prior notification of any meeting
of the Company’s shareholders (and copies of proxy materials
and other information sent to shareholders). In the event
of any taking by the Company of a record
of its shareholders for the purpose
of determining shareholders who are
entitled to receive payment of any dividend
or other distribution, any right to subscribe
for, purchase or otherwise
acquire (including by way of merger,
consolidation, reclassification or recapitalization) any share of any class
or any other securities or property,
or to receive any other right, or for the purpose of determining
shareholders who are entitled to vote in connection with any proposed
sale, lease or conveyance of all
or substantially all of the assets of
the Company or any proposed
liquidation, dissolution or winding up of the Company, the Company shall
mail a notice to the Holder, at
least twenty (20) days prior to the record
date specified therein (or thirty (30) days prior to the consummation of
the transaction or event,
whichever is earlier), of the date on which any such
record is to be taken for the purpose of such dividend, distribution,
right or other event, and a brief
statement regarding the amount and character of such
dividend, distribution, right or other event
to the extent known at such time. The Company shall
make a public announcement of
any event requiring notification to the Holder
hereunder substantially simultaneously with the notification to the Holder
in accordance with the terms of
this Section 4.9.

    	 	14	 

    	 	 	 

    

 

4.10         
Remedies.The Company acknowledges
that a breach by it of its obligations
hereunder will cause irreparable harm to the Holder,
by vitiating the intent
and purpose of the transaction contemplated hereby. Accordingly,
the Company acknowledges that the
remedy at law for a breach of its obligations
under this Note will be inadequate and agrees, in the event
of a breach or threatened breach
by the Company of
the provisions of this Note, that the Holder
shall be entitled, in addition
to all other available remedies at law or in equity,
and in addition to the penalties assessable
herein, to an injunction or injunctions
restraining, preventing or curing any breach
of this Note and to enforce specifically the terms and provisions
thereof, without the necessity of showing economic loss and
without any bond or other security being required.

 

 

IN
WITNESS WHEREOF, Company
has caused this Note to be signed in its
name by its duly authorized
officer:

 

 

Rich
Pharmaceuticals, Inc.

 

By: /s/
Ben Chang

Print:
Ben Chang

Ben
Chang

Title/Date:
CEO / 11.3.17 

    	 	15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00277-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00277-of-00352.parquet"}]]